Patent · US Active

Aryl substituted pyrimidines for use in influenza virus infection

US10611755B2 · kind B2 · utility

1Cited by

4References

8Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
David Craig McGowan · Vilvoorde, BE
Jérôme Emile Georges Guillemont · Andé, FR
Werner Constant Johan Embrechts · Beerse, BE
Guillaume Jean Maurice Mercey · Issy-les-Moulineaux, FR
Christophe Francis Robert Nestor Buyck · Temse, BE
Wendy Mia Albert Balemans · Kalmthout, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

Filing date	Jan 19, 2017
Grant date	Apr 7, 2020
Priority date	—
Expiry date	Jan 19, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds having the structure of formula (I) which can be used for the treatment of or against influenza infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.